Overview
Background
I am the Interim Director at The University of Queensland’s Centre for the Business and Economics of Health (CBEH). I also lead Health Technology Assessment for the Centre, which involves evaluating submissions made to the Australian Government to reimburse new medicines and medical devices through the Pharmaceutical Benefits Scheme (PBS) and the Medicare Benefits Schedule (MBS). My research is focused on the economic evaluation of health interventions to inform decision making and promote value-based health care. I have pioneered the application of Value of Information (Research) analysis to enhance the efficiency of clinical trials and maximise the return on investment from medical research.
I have extensive experience working with key stakeholders including consumers, clinicians, decision makers and researchers. I am chief investigator on over $40 million Category 1 grants from the NHMRC, MRFF and ARC. In addition, I lead several projects for the Department of Health and other peak organisations.
I chair the International Society for Pharmacoeconomics and Outcomes Research (ISPOR)-Oncology Group, and I am the past chair of the Clinical Oncology Society of Australia's (COSA)-Epidemiology Group and the Australian Clinical Trials Alliance (ACTA)-Research Prioritisation Group. I am an Associate Editor for Value in Health, and an Editorial Board Member for Medical Decision Making and PharmacoEconomics-open journals.
Availability
- Professor Haitham Tuffaha is:
- Available for supervision
- Media expert
Fields of research
Qualifications
- Doctor of Philosophy, Griffith University
Research interests
-
Economic Evaluation of Healthcare Interventions
-
Health Technology Assessment
-
Value-Based Health Care
-
Cancer Economics
-
Medications use and safety
Research impacts
My research has significantly influenced health policy in Australia and internationally and was pivotal in the allocation of almost $1 billion in new drugs and medical technologies in Australia over the past ten years. My research program about evaluating new health technologies using Value of Information/implementation analyses led to a paradigm shift in the economic evaluation of new interventions and improved patient access to health innovations (e.g., genetic testing, targeted therapies). My research shifted the way clinical trials are prioritised and funded towards a value-based approach, which informed the development of the Australian Clinical Trials Alliance Research Prioritisation Framework.
I have published over 100 peer reviewed articles and technical reports for leading organisations, including 45 technical reports for the Australian Government on the economic evaluation of novel drugs, devices and services for a range of conditions including cancer, genetic testing, cardiovascular disease and liver disease.
Works
Search Professor Haitham Tuffaha’s works on UQ eSpace
2019
Journal Article
Improving medication adherence in people with dementia through a technological design
El‐Saifi, Najwan, Moyle, Wendy, Jones, Cindy J. and Tuffaha, Haitham W. (2019). Improving medication adherence in people with dementia through a technological design. Journal of Pharmacy Practice and Research, 49 (5), 482-485. doi: 10.1002/jppr.1551
2019
Journal Article
A framework to prioritise health research proposals for funding: integrating value for money
Tuffaha, Haitham W., Aitken, Joanne, Chambers, Suzanne and Scuffham, Paul A. (2019). A framework to prioritise health research proposals for funding: integrating value for money. Applied Health Economics and Health Policy, 17 (6), 761-770. doi: 10.1007/s40258-019-00495-2
2019
Journal Article
International HTA experience with targeted therapy approvals for lung cancer
Maraiki, Fatma, Byrnes, J., Tuffaha, H. and Hinder, M. (2019). International HTA experience with targeted therapy approvals for lung cancer. PharmacoEconomics - Open, 3 (1), 103-117. doi: 10.1007/s41669-018-0088-x
2019
Conference Publication
Value for money of putting precision into practice: Germline genetic testing to guide olaparib treatment in HER2-negative metastatic breast cancer
Tuffaha, Haitham and Scuffham, Paul (2019). Value for money of putting precision into practice: Germline genetic testing to guide olaparib treatment in HER2-negative metastatic breast cancer. COSA's 46th Annual Scientific Meeting, Urological cancer; Age and gender in cancer practice; Digital health in cancer, Adelaide, Australia, 12–14 November 2019. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.13262
2019
Conference Publication
PCN95 cost-effectiveness analysis of germline BRCA mutation testing and olaparib treatment in metastatic breast cancer: an evaluation of codependent technologies
Tuffaha, H. and Scuffham, P. (2019). PCN95 cost-effectiveness analysis of germline BRCA mutation testing and olaparib treatment in metastatic breast cancer: an evaluation of codependent technologies. ISPOR Europe 2019, Copenhagen, Denmark, 2-6 November 2019. New York, NY United States: Elsevier. doi: 10.1016/j.jval.2019.09.292
2019
Conference Publication
Cost-effective analysis of supervised exercise training in men with prostate cancer previously treated with androgen deprivation therapy and radiation
Edmunds, Kim, Reeves, Penny, Tuffaha, Haitham, Galvao, Daniel, Newton, Rob, Spry, Nigel, Denham, James, Taaffe, Dennis R., Joseph, David, Lamb, David S., Chambers, Suzanne K. and Scuffham, Paul (2019). Cost-effective analysis of supervised exercise training in men with prostate cancer previously treated with androgen deprivation therapy and radiation. COSA's 46th Annual Scientific Meeting, Urological cancer; Age and gender in cancer practice; Digital health in cancer, Adelaide, SA, Australia, 12–14 November 2019. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.13262
2019
Conference Publication
PCN349 Value of information analysis guiding the reimbursement decision of olaparib for metastatic breast cancer
Tuffaha, H. and Scuffham, P. (2019). PCN349 Value of information analysis guiding the reimbursement decision of olaparib for metastatic breast cancer. ISPOR Europe 2019, Copenhagen, Denmark, November 2019. New York, NY, United States: Elsevier. doi: 10.1016/j.jval.2019.09.544
2019
Journal Article
New challenges in psycho-oncology: economic evaluation of psychosocial services in cancer: challenges and best practice recommendations
Tuffaha, Haitham, El-Saifi, Najwan, Chambers, Suzanne and Scuffham, Paul (2019). New challenges in psycho-oncology: economic evaluation of psychosocial services in cancer: challenges and best practice recommendations. Psycho-Oncology, 28 (1), 3-10. doi: 10.1002/pon.4933
2018
Journal Article
Directing research funds to the right research projects: a review of criteria used by research organisations in Australia in prioritising health research projects for funding
Tuffaha, Haitham W., El Saifi, Najwan, Chambers, Suzanne K. and Scuffham, Paul A. (2018). Directing research funds to the right research projects: a review of criteria used by research organisations in Australia in prioritising health research projects for funding. BMJ Open, 8 (12) e026207, e026207. doi: 10.1136/bmjopen-2018-026207
2018
Other Outputs
Implementation of GCPHN Evaluation Framework – COPD After Hours and Persistent Pain Program
Vecchio, Nerina, Tuffaha, Haitham, Radford, Katrina and Chai, Andreas (2018). Implementation of GCPHN Evaluation Framework – COPD After Hours and Persistent Pain Program. Gold Coast, QLD, Australia: Griffith University.
2018
Journal Article
Cost of vascular access devices in public hospitals in Queensland
Tuffaha, Haitham W., Marsh, Nicole, Byrnes, Joshua, Gavin, Nicole, Webster, Joan, Cooke, Marie and Rickard, Claire M. (2018). Cost of vascular access devices in public hospitals in Queensland. Australian Health Review, 43 (5), 511-515. doi: 10.1071/AH18102
2018
Journal Article
Dressings and securements for the prevention of peripheral intravenous catheter failure in adults (SAVE): a pragmatic, randomised controlled, superiority trial
Rickard, Claire M., Marsh, Nicole, Webster, Joan, Runnegar, Naomi, Larsen, Emily, McGrail, Matthew R., Fullerton, Fiona, Bettington, Emilie, Whitty, Jennifer A., Abu Choudhury, Md, Tuffaha, Haitham, Corley, Amanda, McMillan, David J., Fraser, John F., Marshall, Andrea P. and Playford, E. Geoffrey (2018). Dressings and securements for the prevention of peripheral intravenous catheter failure in adults (SAVE): a pragmatic, randomised controlled, superiority trial. Lancet, 392 (10145), 419-430. doi: 10.1016/S0140-6736(18)31380-1
2018
Journal Article
Medication adherence in older patients with dementia: a systematic literature review
El-Saifi, Najwan, Moyle, Wendy, Jones, Cindy and Tuffaha, Haitham (2018). Medication adherence in older patients with dementia: a systematic literature review. Journal of Pharmacy Practice, 31 (3), 322-334. doi: 10.1177/0897190017710524
2018
Journal Article
The Australian managed entry scheme: are we getting it right?
Tuffaha, Haitham W. and Scuffham, Paul A. (2018). The Australian managed entry scheme: are we getting it right?. Pharmacoeconomics, 36 (5), 555-565. doi: 10.1007/s40273-018-0633-6
2018
Journal Article
Estimating the healthcare costs of treating prostate cancer in Australia: A Markov modelling analysis
Gordon, Louisa G., Tuffaha, Haitham W., James, Robbie, Keller, Andrew T., Lowe, Anthony, Scuffham, Paul A. and Gardiner, Robert A. (2018). Estimating the healthcare costs of treating prostate cancer in Australia: A Markov modelling analysis. Urologic Oncology, 36 (3) ARTN 91.e7, e7-e15. doi: 10.1016/j.urolonc.2017.10.024
2018
Journal Article
Cost-effectiveness analysis of germ-line BRCA testing in women with breast cancer and cascade testing in family members of mutation carriers
Tuffaha, Haitham W., Mitchell, Andrew, Ward, Robyn L., Connelly, Luke, Butler, James R. G., Norris, Sarah and Scuffham, Paul A. (2018). Cost-effectiveness analysis of germ-line BRCA testing in women with breast cancer and cascade testing in family members of mutation carriers. Genetics in Medicine : Official Journal of the American College of Medical Genetics, 20 (9), 985-994. doi: 10.1038/gim.2017.231
2018
Conference Publication
Can we prospectively assess the value for money of oncology clinical trials?
Tuffaha, Haitham, Chambers, Suzanne and Scuffham, Paul (2018). Can we prospectively assess the value for money of oncology clinical trials?. COSA's 45th Annual Scientific Meeting, Mesothelioma and Gastro‐Intestinal Cancers: Technology and Genomics, Perth, WA Australia, 13–15 November 2018. Chichester, West Sussex United Kingdom: Wiley-Blackwell. doi: 10.1111/ajco.13089
2018
Conference Publication
Can technology improve medication adherence in older people with dementia?
El-Saifi, Najwan, Moyle, Wendy, Jones, Cindy and Tuffaha, Haitham (2018). Can technology improve medication adherence in older people with dementia?. 16th International Conference, ICOST 2018, Singapore, 10-12 July, 2018. Cham, Switzerland: Springer. doi: 10.1007/978-3-319-94523-1_1
2018
Conference Publication
Value For Money, the Overlooked Aspect in Research Funding Decisions
Tuffaha, H., El-Saifi, N. and Scuffham, P. (2018). Value For Money, the Overlooked Aspect in Research Funding Decisions. Moving Into Action: Informing Policy and Strengthening Healthcare Systems in Asia-Pacific, Tokyo, Japan, 8-11 September 2018. Elsevier. doi: 10.1016/j.jval.2018.07.413
2018
Conference Publication
Rare Cancers, no Rare Solutions: Risk Sharing Arrangemnts to Reimburse Medicines for Rare Cancers in Australia
Tuffaha, H. and Scuffham, P. (2018). Rare Cancers, no Rare Solutions: Risk Sharing Arrangemnts to Reimburse Medicines for Rare Cancers in Australia. Moving Into Action: Informing Policy and Strengthening Healthcare Systems in Asia-Pacific, Tokyo, Japan, 8-11 September 2018. Elsevier. doi: 10.1016/j.jval.2018.07.839
Funding
Current funding
Supervision
Availability
- Professor Haitham Tuffaha is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Supervision history
Current supervision
-
Doctor Philosophy
Evaluation of Indonesian Chronic Diseases Management Program: Patients participation, adherence to the treatment and cost-effectiveness of the program
Principal Advisor
Other advisors: Associate Professor Adam La Caze, Dr Kim Edmunds
-
Doctor Philosophy
Assessing the Value for Money of Integrating Exercise as Therapy after Gynaecological Cancer Treatment
Principal Advisor
Other advisors: Professor Sandie McCarthy
Media
Enquiries
Contact Professor Haitham Tuffaha directly for media enquiries about:
- Cancer Economics
- Health Economics
- Health Services Research
Need help?
For help with finding experts, story ideas and media enquiries, contact our Media team: